Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Short-term variability in measures of glycemia and implications for the classification of diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycated hemoglobin measurement and prediction of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Lifestyle intervention strategies to prevent and control type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Pharmacologic treatment options for obesity: what is old is new again

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

A cardiac magnetic resonance imaging study of electrocardiographic Q waves in type 2 diabetes: the Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prognostic value of coronary artery calcium screening in subjects with and without diabetes.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Self-Monitoring in Weight Loss: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Trends in mortality in bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

STOP regain: are there negative effects of daily weighing?

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Maintaining large weight losses: the role of behavioral and psychological factors

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Consistent self-monitoring of weight: a key component of successful weight loss maintenance

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

One-year weight losses in the Look AHEAD study: factors associated with success

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Discrepancy between self-reported and actual caloric intake and exercise in obese subjects.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Do Lifestyle Changes Reduce Serious Outcomes in Diabetes?

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Perioperative safety in the longitudinal assessment of bariatric surgery

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Multicenter, placebo-controlled trial of lorcaserin for weight management

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Severe hypoglycemia and risks of vascular events and death

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Bariatric surgery versus conventional medical therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Basal insulin and cardiovascular and other outcomes in dysglycemia

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diverse causes of hypoglycemia-associated autonomic failure in diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Achievement of goals in U.S. diabetes care, 1999-2010.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Nutrients and cardiovascular disease: no easy answers

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Susceptibility of LDL and its subfractions to glycation

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Bariatric surgery: an IDF statement for obese Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American Co

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Serious cardiovascular outcomes in diabetes: the role of hypoglycemia

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Medical therapy for the patient with obesity

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Surgical management of obesity and the relationship to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

A review of variant hemoglobins interfering with hemoglobin A1c measurement

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Clinical review: Screening for coronary artery disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Estimate of biological variation of laboratory analytes based on the third national health and nutrition examination survey

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Kidney disease and increased mortality risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The barrier of hypoglycemia in diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Screening for coronary artery disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Hypoglycemia, diabetes, and cardiovascular events

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Performance of A1C for the classification and prediction of diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

A1C Versus Glucose Testing: A Comparison

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study.

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Hypoglycemia and cardiovascular risks

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Severe hypoglycemia predicts mortality in diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Nutrition therapy recommendations for the management of adults with diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Standards of Medical Care in Diabetes--2015: Summary of Revisions

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Fish oil supplementation in type 2 diabetes: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Increased prevalence of significant coronary artery calcification in patients with diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Treatment of the obese patient in primary care: targeting and meeting goals and expectations

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021

Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1161%2FCIR.0000000000000230

7 January 2021